Free shipping on all orders over $ 500

MRTX849 (Adagrasib)

Cat. No. M9428
MRTX849 (Adagrasib) Structure

Adagrasib; MRTX-849

Size Price Availability Quantity
5mg USD 67.5  USD75 In stock
10mg USD 103.5  USD115 In stock
25mg USD 225  USD250 In stock
50mg USD 405  USD450 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

MRTX849 (Adagrasib) is a potent, highly selective, oral available KRAS G12C inhibitor. MRTX849 (Adagrasib) maximizes inhibition by irreversibly locking the KRAS molecule in its inactive state, thereby preventing tumor cell growth which results in tumor cell death. MRTX849 (Adagrasib) exhibited significantly improved half-life and penetration into the tumor, shutting down KRAS signaling for the entire dosing interval, and showing a higher degree of antitumor activity than previous KRAS mutant-selective inhibitors.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 604.12
Formula C32H35ClFN7O2
CAS Number 2326521-71-3
Purity 99.48%
Solubility DMSO ≥ 30 mg/mL
Storage -20°C, dry, sealed

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Pat lents.
Hallin J, et al. Cancer Discov. 2020 Jan;10(1):54-71. PMID: 31658955.

Related Ras Products
CID-1067700 (ML282)

CID-1067700 (ML282) is a competitive inhibitors of nucleotide binding by Ras-related GTPases with a Ki of 13 nM for Rab7.


MLS000532223 is a selective inhibitor of Rho family GTPases, with EC50 ranging from 16 μM to 120 μM.


BI-3406 is a highly potent and selective SOS1::KRAS inhibitor (IC50=6 nM), which selectively binds to SOS1 and blocks the interaction with KRAS, irrespective of the KRAS mutation.


ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor with IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N), respectively.


BI-2852 is a potent KRAS inhibitor that binds with nanomolar affinity to a pocket.

Abmole Inhibitor Catalog 2017

Keywords: MRTX849 (Adagrasib), Adagrasib; MRTX-849 supplier, Ras, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.